Organized by:

Financial Times Live

Financial Times Live


+852 2905 5515

Event Information

Disruption and transformation will continue to be the focus of life science leaders in 2019 and beyond.


Pricing pressures in the US and a growing number of markets globally has already set in motion a search for new and innovative payment models, while the rise of ultra-expensive, potentially curative gene and cell therapies has brought to the fore a heated discussion about the sustainability of industry’s underlying economic and funding model.

Venue & Direction

Event Speakers




Exhibitors Profile

Visitors Profile

•  Pharmaceutical companies
•  Biotechnology companies
•  Diagnostic and medical device
•  CROs
•  Healthcare providers and insurers
•  Government healthcare departments, HTA’s and drug regulators
•  IT, big data and analytics providers
•  Health economists
•  Healthcare investment bankers, private equity
•  Patient representatives and NGOs

Event Partners